Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2356 of 5804
-
New gel injection aims to tame gout flare pain in days
Symptom relief Recruiting nowThis is a randomized, multicenter, double-blind, single administration study to investigate the efficacy and safety of 2 dosing regimens of Purified Cortrophin® Gel in the treatment of an acute gouty arthritis flare. The study consists of three periods: an optional pre-screening…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Stomach bug treatment may relieve chronic gut discomfort
Disease control Not yet recruitingThis study aims to evaluate the effect of Helicobacter pylori eradication on gastrointestinal symptoms in adult patients. H. pylori infection is a common cause of dyspepsia and other upper gastrointestinal complaints. The trial will assess whether successful eradication therapy l…
Sponsor: Amany Usama Ahmed Arafa • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Spine surgery showdown: cemented screws vs. standard screws for brittle bones
Disease control Recruiting nowThis study aims to compare the clinical and radiological outcomes of bone-cement-augmented transpedicular screw fixation versus cannulated pedicle screw fixation in patients with osteoporotic spines requiring posterior instrumentation, with respect to implant stability (loosening…
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New acid blocker vonaprazan takes on esomeprazole in reflux healing showdown
Disease control Recruiting nowPrimary Objective • To compare the healing rates of LA grade B or higher reflux esophagitis at 8 weeks among patients treated with Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg once daily. Secondary Objectives * To assess the improvement in reflux symptoms using t…
Phase: NA • Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Brain scans reveal how back pain rewires the mind
Knowledge-focused Not yet recruitingThrough longitudinal analysis of dynamic changes in DMN functional connectivity before and after sensory training intervention, combined with pain behavioral and functional improvement indicators, this study systematically reveals the central neural remodeling patterns in CNLBP a…
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New study aims to ease chronic pain without pills for military personnel
Symptom relief Recruiting nowThe goal of this study is to improve pain care in the MHS by identifying effective, whole-person, non-pharmacologic interventions for persons with chronic musculoskeletal pain. The investigators will evaluate two promising, evidence-based holistic health interventions and compare…
Phase: NA • Sponsor: Brooke Army Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Radiation or steroids? new study tests better pain relief for arthritic hands
Symptom relief Recruiting nowThe purpose of this research is to compare low-dose radiotherapy to corticosteroid injection for treatment of hand/wrist osteoarthritis.
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could CBD oil soothe restless legs? new study seeks answers
Symptom relief Not yet recruitingThis study plans to learn more about the safety and tolerability of high Cannabidiol (CBD) cannabis extract (BRC-002) for use in Idiopathic Restless Legs Syndrome. Symptoms and side effects experienced while taking the study drug will be tracked to determine if this medication is…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New ALS drug trial launches: hope for slowing the disease?
Disease control Recruiting nowPIONEER-ALS is a Phase 1/2, multicenter, open-label, ascending dose, uncontrolled, first-in-human study that will evaluate the safety, tolerability and effects on clinical and biomarker endpoints of intracisternal administration of Vtx-002 in participants with Amyotrophic Lateral…
Phase: PHASE1, PHASE2 • Sponsor: Vector Y Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Online parenting program aims to curb teen drug use in latinx families
Prevention Recruiting nowLatinx people are the largest and fastest growing minority population in the U.S., yet most lack access to community responsive preventative interventions to reduce substance use among youth. Effective implementation of evidence-based interventions that can be delivered online is…
Phase: NA • Sponsor: University of Oregon • Aim: Prevention
Last updated Jun 27, 2026 13:03 UTC
-
New flexible scope aims to zap kidney stones in one go
Symptom relief OngoingThis prospective pilot study aims to evaluate the feasibility, safety, and preliminary clinical outcomes of a novel mini-percutaneous nephrolithotomy (mini-PCNL) technique integrating a flexible mini-nephroscope with a flexible and navigable suction access sheath (FANS) for the t…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New spinal implant for kids with scoliosis under Long-Term safety review
Disease control Recruiting nowThe NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children. As part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth do…
Phase: NA • Sponsor: EUROS • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can computer games and meditation heal young brains after cancer?
Symptom relief Recruiting nowThis randomized controlled clinical trial evaluates neurocognitive, biopsychological, and brain connectome outcomes in children and adolescents with acute lymphoblastic leukemia who have previously received Chimeric Antigen Receptor T-cell therapy (CAR T-cell therapy), chemothera…
Phase: NA • Sponsor: Hospital Universitario La Paz • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Could a simple amino acid shorten diabetic emergencies?
Disease control Recruiting nowDiabetic ketoacidosis (DKA) is increasingly recognized in adults with "ketone-prone" type 2 diabetes. In many of these patients, the pancreas can still make insulin but becomes temporarily "stunned" during severe, prolonged high blood sugar. Arginine is a naturally occurring amin…
Phase: PHASE1, PHASE2 • Sponsor: David K Carroll • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could a menopause drug cool hot flashes in men with prostate cancer?
Symptom relief Recruiting nowThis study is for men with prostate cancer who are experiencing hot flashes due to treatments that lower testosterone. Hot flashes can affect your quality of life and make it harder for patients to continue their treatment, so researchers want to find a better way to manage them.…
Phase: PHASE2 • Sponsor: University of Vermont • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Could a tiny dose of radiation tame this skin cancer?
Disease control OngoingPrimary indolent cutaneous B cell lymphomas (PCBCL) are rare: although data on outcomes and treatment are limited, traditionally they have been treated with radiation doses in excess of 24 Gy. Recently, some trials that patients with primary cutaneous indolent lymphoma managed wi…
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo aims to outsmart resistant lung cancer
Disease control Recruiting nowThis is a multi-center, open label, Phase 1b study of NXP900 in combination with osimertinib in subjects with advanced, progressing, EGFR-mutated non-small cell lung cancer (NSCLC)
Phase: PHASE1 • Sponsor: Nuvectis Pharma, Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug NM6603 enters first human tests for advanced cancers
Disease control Recruiting nowThis study is to assess the MTD and PK of NM6603 in adult patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: NucMito Pharmaceuticals Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could 3D imaging during breast surgery cut down repeat operations?
Knowledge-focused Recruiting nowBreast-conserving surgery is commonly performed to remove early-stage breast cancer or ductal carcinoma in situ (DCIS). During surgery, the goal is to completely remove the tumour with a clear margin of normal tissue around it. If cancer cells are found at the edge of the removed…
Phase: NA • Sponsor: Royal College of Surgeons, Ireland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Can a quicker MRI beat ultrasound for spotting liver cancer?
Knowledge-focused Recruiting nowDETECT-HCC-ESLD is a prospective multicenter study designed to examine early detection and risk stratification of hepatocellular carcinoma (HCC) in individuals with advanced liver disease. Adults with cirrhosis of different etiologies are enrolled and followed longitudinally with…
Sponsor: Mattias Ekstedt • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC